Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-7 of  7 results for ""Forbes SG""

Your Filters

Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Implementation and Evaluation of a Clinical Trial Communication Tool for Frontline Clinical Staff.

Subjects: Communication* ; Patient Care Team*; Humans

  • Source: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2023 Nov 16; Vol. 27 (6), pp. 663-667.Publisher: Oncology Nursing Press Country of Publication: United States NLM ID: 9705336 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Ethical Challenges Encountered by Clinical Trials Nurses: A Grounded Theory Study.

Subjects: Attitude of Health Personnel*; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*ethics ; Nursing Research/Nursing Research/Nursing Research/*ethics

  • Source: Oncology nursing forum [Oncol Nurs Forum] 2020 Jul 01; Vol. 47 (4), pp. 428-435.Publisher: Oncology Nursing Society Country of Publication: United States NLM ID: 7809033 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Immune-Mediated Therapies in Lymphoma.

  • Authors : Forbes SG; M.D. Anderson Cancer Center, Houston, TX. Electronic address: .; Mistry HE

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Immunologic Factors/Immunologic Factors/Immunologic Factors/*therapeutic use

  • Source: Seminars in oncology nursing [Semin Oncol Nurs] 2019 Oct; Vol. 35 (5), pp. 150925. Date of Electronic Publication: 2019 Sep 13.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 8504688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lenalidomide plus rituximab (R 2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.

  • Authors : Becnel MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lenalidomide/Lenalidomide/Lenalidomide/*therapeutic use

  • Source: British journal of haematology [Br J Haematol] 2019 Jun; Vol. 185 (5), pp. 874-882. Date of Electronic Publication: 2019 Mar 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Low carbohydrate, high fat diet impairs exercise economy and negates the performance benefit from intensified training in elite race walkers.

  • Authors : Burke LM; Sports Nutrition, Australian Institute of Sport, Canberra, Australia, 2616.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia, 3000.

Subjects: Athletic Performance* ; Physical Conditioning, Human*; Diet, Carbohydrate-Restricted/Diet, Carbohydrate-Restricted/Diet, Carbohydrate-Restricted/*adverse effects

  • Source: The Journal of physiology [J Physiol] 2017 May 01; Vol. 595 (9), pp. 2785-2807. Date of Electronic Publication: 2017 Feb 14.Publisher: Cambridge Univ. Press Country of Publication: England NLM ID: 0266262 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*toxicity ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*nursing ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*drug therapy

  • Source: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2017 Apr 01; Vol. 21 (2 Suppl), pp. 53-59.Publisher: Oncology Nursing Press Country of Publication: United States NLM ID: 9705336 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Report

Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma.

  • Authors : Cheah CY; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nastoupil LJ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Lymphoma/Lymphoma/Lymphoma/*drug therapy; Aged

  • Source: Blood [Blood] 2015 May 21; Vol. 125 (21), pp. 3357-9.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
  • 1-7 of  7 results for ""Forbes SG""